The Hill: For Thousands Of Common Chemicals, There Is ‘No Safe Level,’ Says Report

Swirling ocean water that it foamed in swirls.
March 1, 2024
The Hill covers a new report headed by Professor of Pharmacology & Toxicology Andrea Gore, Ph.D. that draws attention to the link between plastics, pesticides and forever chemicals and the growing incidence of endocrine-associated disorders over the last two decades.

Gore Earns NIH Award for Research on Endocrine-disrupting Chemicals

Molecules and other objects floating around a human brain.
July 12, 2023
Andrea C. Gore, Ph.D., professor of pharmacology and toxicology and Vacek Chair in Pharmacology, recently earned an R35 RIVER grant award from the National Institute of Environmental Health Sciences (NIEHS) for her lab’s research on endocrine-disrupting chemicals (EDCs) and their effect on the brain. The NIEHS, which is one of the centers in the National Institutes of Health (NIH), awarded a total of $6,823,672 for eight years.

FDA Considers Making Narcan Opioid Overdose Antidote Available Without Prescription

Two hands cradling a nasal spray dispenser for naloxone.
February 15, 2023
Clinical Associate Professor in the Division of Pharmacotherapy Dr. Kirk Evoy spoke to CNN about the possibilities of making naloxone, a medication used to reverse or reduce the effects of opioids, available over-the-counter.

Reveles and Evoy Earn Promotions

A woman and a man smiling.
February 25, 2022
Two of the college's distinguished faculty in the Division of Pharmacotherapy were recommended for promotion by President Hartzell. Dr. Kelly R. Reveles will assume the rank of associate professor and Dr. Kirk Evoy will become a clinical associate professor. Both promotions go into effect September 1, 2022.

TxCORE Research Wins PhRMA Foundation Award

Three people smiling.
April 1, 2021
Three researchers from the College of Pharmacy won an award from the Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation. Leticia R. Moczygemba, Pharm.D., Ph.D., Carolyn M. Brown, Ph.D. and Michael Johnsrud, Ph.D., R.Ph. were awarded $5,000 from the PhRMA Foundation for their proposal to advance racial and ethnic representation in value assessments.

Laura Cannon: An Empathetic Voice for Patients & Students

A woman smiling.
January 5, 2021
Laura Cannon, Pharm.D., MPH, is an oncology pharmacist and clinical assistant professor at the UT College of Pharmacy. She was in her residency when her late husband was diagnosed with cancer. Her experience shapes her unique perspective as she works to simplify the education process surrounding cancer treatment.

In Remembrance of Dr. Ted Mills

A man wearing a suit and tie.
October 23, 2020
It is with great sadness that we announce the passing of Edward (Ted) Mills, Ph.D., associate professor in the Division of Pharmacology and Toxicology and Bergen Brunswig Corporation Centennial Fellow.

Inhaled Niclosamide a Potential Effective Antiviral to Treat COVID-19

An infrared image of nasal spray being administered.
September 29, 2020
Researchers in the lab of Dr. Hugh D.C. Smyth have released promising results of a new method to treat SARS-CoV-2, the coronavirus that causes COVID-19. The antiviral niclosamide, when incorporated with human lysozyme as a carrier molecule, shows potential as an effective COVID-19 treatment when delivered directly to the airways.

Gore receives five-year NIH grant to research PCBs

gore large
April 2, 2019
Pharmacology and Toxicology Professor Andrea C. Gore, Ph.D. recently received an impressive five-year RO1 grant from the National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes for Health (NIH), for research to determine how PCBs cause dysfunctions in reproductive physiology and behavior.